93例服用阿司匹林患者的调查分析
摘要
为了解患者对阿司匹林的认知程度和正确应用方法,保证治疗疗效和服药安全.我们对正在服用阿司匹林的93例患者进行了详细调查,报道如下:
出处
《医学动物防制》
2005年第6期399-400,共2页
Journal of Medical Pest Control
二级参考文献14
-
1Pearson TA, Mensah GA, Alexander RW, et al. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the Americ
-
2Altrman R, Luciardi HL, Muntaner J, et al. Efficacy assessment of meloxicam, a preferential cyclooxygenase - 2 inhibitor, in acute coronary syndromes without ST - segment elevation: the Nonsteroidal Anti- Inflammatory Drugs in Unstable Angina Treatment -
-
3Antithrombotic Trialists Collaboration. Collaborative meta- analysis of randomized trial of antiplatelet therapy for prevention of death, myocardial infarction and stroke in high risk patients[J ].BM J, 2002,324( 1 ): 71-86
-
4Crofford LJ, LIpsky PE, Brooks P, et al. Basic biology and application of specific cyclooxygenase - 2 inhibitors [ J ]. Arth & Rheum,2000,43(1) :4-13
-
5Chenvard R, Hurlimann D, Bechir M, et al. Selective COX - 2 improves endothelial function in coronary artery disease[J ]. Circulation, 2003,107 (1): 405-409
-
6Linton MF, Fazios D. Cyclooxygenase - 2 and atherosclerosis [J]. Current Opin Lipidol,2002,13(2) :497-504
-
7Burleigh ME, Babaev VR, Oatos JA, et al. Cyclooxygenase - 2 promotes early, athroeclerotic lesion formation in LDL receptor - deficient mice[J ]. Circulation, 2002,105(9) :1816-1823
-
8Baigeut C, Patron C. Selective cyclooxygenase - 2 inhibitors, aspirin, and cardiovascular disease [ J ]. Arth & Rheum, 2003, 48(1):12-20
-
9Silverstein FE,Faich G,Goldsten JT,et al. Gastrointestinal toxicity with celecoxib vs NSAID for osteoarthritis and rheumatoid arthritis. The CLASS study [ J ]. JAMA, 2000, 284 ( 6 ): 1247-1255
-
10Catella - Lawson F, Reilly MP, Kapoor SC, et al. Cyclooxygenase inhibitors and the antiplatelet effects of aspirin[J ]. New Eng J Med, 2001,345(8): 1809-1817
共引文献11
-
1罗良回.浅谈阿司匹林的药物相互作用与临床应用新途径[J].医学信息(医学与计算机应用),2014,0(9):513-513.
-
2王月华.肠溶阿司匹林防治高危患者脑卒中的疗效对比[J].实用心脑肺血管病杂志,2006,14(1):60-61.
-
3孙卫东.阿司匹林在心血管病防治中的合理应用[J].中国社区医师,2007,23(2):15-16. 被引量:1
-
4俞万香,李水彬,侯飞雁.阿司匹林与丹参在短暂性脑缺血发作临床防治中的对照研究[J].广东药学院学报,2007,23(3):338-339. 被引量:1
-
5杨健全.阿司匹林治疗短暂性脑缺血发作60例疗效观察[J].航空航天医药,2009,20(12):95-96. 被引量:12
-
6胡亚琼.低分子肝素联合阿司比林治疗短暂性脑缺血发作临床观察[J].中国社区医师(医学专业),2010,12(21):33-33. 被引量:1
-
7聂献真,储彦丽.肠溶阿司匹林联合双密达莫治疗脑血栓140例疗效分析[J].吉林医学,2010,31(35):6492-6492. 被引量:4
-
8周永生.肠溶阿司匹林联合双密达莫治疗脑血栓的临床分析[J].中国中医药咨讯,2011,3(22):187-187. 被引量:3
-
9楼凤仙.对60例使用阿司匹林患者的调查分析[J].内蒙古中医药,2012,31(9):110-110.
-
10孟传萍.阿司匹林肠溶片联合双嘧达莫治疗脑血栓的临床效果[J].中国医药指南,2013,11(2):43-44. 被引量:19
-
1按说明书服药安全吗[J].四川劳动保障,2004(4):21-21.
-
2杨颖梅.老年糖尿病患者口服用药存在问题及对策[J].中国伤残医学,2012,20(9):71-72. 被引量:7
-
3王小蓓.老年高血压住院患者服药安全的实践与思考[J].中国老年保健医学,2008,6(4):53-54.
-
4黄辰.老人服药误区多[J].中华养生保健,2012(12):11-12.
-
5屈红.老年病区确保服药安全的管理[J].中外医疗,2008,27(24). 被引量:1
-
6丘振文,廖小红.准妈妈,外用药须小心[J].家庭药师,2014(8):42-43.
-
7梁旭亚,徐爱琴,孟爱仙.住院老年痴呆患者服药安全影响因素分析与护理干预对策[J].中医药管理杂志,2016,24(8):83-84. 被引量:6
-
8吴韵.试析影响中药制剂临床疗效的几个因素[J].药物与人,2014,27(7):131-132.
-
9宋永亮.老年痴呆住院患者服药安全影响因素分析与安全对策[J].中医药管理杂志,2015,23(23):80-81. 被引量:2
-
10丘振文,廖小红.准妈妈,外用药不一定安全[J].中国家庭医生,2014(8):41-41.